期刊文献+

小鼠转移性乳腺癌骨髓细胞体外净化移植模型的建立

Establishment and application of a murine transplant model of bone marrow purging of metastatic breast cancer cells in vitro
原文传递
导出
摘要 目的建立一个小鼠转移性乳腺癌净化后骨髓移植模型,并探讨益康唑(Econazole,Ec)药物净化效果。方法将小鼠自发性乳腺癌细胞系 TSA 转染新霉素抗性基因(Neo^R 基因)后与小鼠骨髓细胞混合,体外短期培养净化;通过移植后造血恢复,肺转移性结节和小鼠的存活进行评估。结果接受放射治疗后经尾静脉注射 TSA 细胞的小鼠均可产生乳腺癌肺转移;Ec 体外净化后骨髓移植小鼠造血恢复没有明显延迟,移植后4周内未见肺转移性结节;小鼠的总生存状况明显改善。结论成功建立了 TSA 小鼠乳腺癌净化后骨髓移植模型,方法简单、易行、重复性好;Ec 可用于转移性乳腺癌净化后骨髓移植。 Objective To establish a murine transplant model for bone marrow purging of metastatic breast cancer and to explore the efficiency of Econazole (Ec) as a purging agent. Methods Mixtures of TSA /NeoR breast cancer cells and murine bone marrow cells were transplanted into lethally irradiated mice following purging with Econazole or saline in vitro. The recipient mice were monitored for hematopoietic engraftment, appearance of metastatic nodules in lungs and the overall survival. Results All the mice receiving i.v. injection of TSA cells developed metastatic lung nodules. The hematological recovery was not delayed in mice transplanted with Ec purged bone marrow. More importantly, metastatic lung nodules were not seen in Ec treated group and the overall survival was improved. Conclusion The purged metastatic breast cancer cell bone marrow transplant model was easily established and reproducible. Ec could be used to purge the bone marrow grafts contaminated with breast cancer cells.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第9期621-623,共3页 Chinese Journal of Hematology
关键词 乳腺癌 净化 骨髓移植 Breast cancer Purging Bone marrow transplant
  • 相关文献

参考文献15

  • 1Elfenbein GJ. Stem-cell transplantation for high-risk breast cancer. N Engl J Med, 2003,349:80-82.
  • 2Tallman M, Gray R, Robert N, et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in high-risk breast cancer. N Engl J Med,2003, 349 : 17-26.
  • 3Nieto Y, Jones RB, Shpall EJ. High- dose chemotherapy for breast cancer: is another look warranted? Curr Opin Oncol,2004,16: 114- 119.
  • 4Tartarone A, Romano G, Galasso R, et al. Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of published data. Bone marrow Transplant,2003, 31 : 525-530.
  • 5Soboloff J, Zhang Y, Minden M, et al. Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol,2002,30 : 1219-1226.
  • 6Rodenhuis S, Bontenbal M, Beex L, et al. High-dose chemotherapy with hematopoietic stem cell rescue for high-risk breast cancer. N Engl J Med, 2003,349:7-16.
  • 7Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst, 1966,36:641-645.
  • 8Pecora AL, Lazarus HM, Jennis AA, et al. Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictor and clinical relevance. Biol Blood Marrow Transplant, 2002, 8:536-543.
  • 9Nieto Y, Franklin WA, Jones RB, et al. Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support. Biol Blood Marrow Transplant, 2004, 10:415-425.
  • 10Ferrucci PF, Rabascio C, Mazzetta C, et al. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer. Clin Cancer Res, 2004, 10:6039-6046.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部